{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T14:59:49Z","timestamp":1782313189815,"version":"3.54.5"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.lfs.2016.06.021","type":"journal-article","created":{"date-parts":[[2016,6,26]],"date-time":"2016-06-26T14:48:17Z","timestamp":1466952497000},"page":"98-103","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Effect of risperidone on plasma d-serine concentration in rats post-administered with d-serine"],"prefix":"10.1016","volume":"158","author":[{"given":"Mayu","family":"Onozato","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromi","family":"Nakazawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitomi","family":"Hakariya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miho","family":"Shishikura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chihiro","family":"Nagashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuyuki","family":"Ishimaru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuya","family":"Sakamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideaki","family":"Iizuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideaki","family":"Ichiba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Fukushima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2016.06.021_bb0005","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1056\/NEJMra035458","article-title":"Schizophrenia","volume":"349","author":"Freedman","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.lfs.2016.06.021_bb0010","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1523\/JNEUROSCI.17-05-01604.1997","article-title":"d-serine as a neuromodulator: regional and developmental localizations in rat brain glia resemble NMDA receptors","volume":"17","author":"Schell","year":"1997","journal-title":"J. Neurosci."},{"key":"10.1016\/j.lfs.2016.06.021_bb0015","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1001\/archpsyc.60.6.572","article-title":"Decreased serum levels of d-serine in patients with schizophrenia","volume":"60","author":"Hashimoto","year":"2003","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.lfs.2016.06.021_bb0020","doi-asserted-by":"crossref","first-page":"151","DOI":"10.2174\/1573400054065569","article-title":"Dysfunction of glia-neuron communication in pathophysiology of schizophrenia","volume":"1","author":"Hashimoto","year":"2005","journal-title":"Curr. Psychiatr. Rev."},{"key":"10.1016\/j.lfs.2016.06.021_bb0025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0101652","article-title":"Quantitative analyses of schizophrenia-associated metabolites in serum: serum d-lactate levels are negatively correlated with gamma-glutamylcysteine in medicated schizophrenia patients","volume":"9","author":"Fukushima","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2016.06.021_bb0030","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/S0006-3223(98)00279-0","article-title":"d-Serine added to antipsychotics for the treatment of schizophrenia","volume":"44","author":"Tsai","year":"1998","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.lfs.2016.06.021_bb0035","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.biopsych.2004.12.037","article-title":"d-serine efficacy as add-on pharmacotherapy to risperidone and olanzapine for treatment-refractory schizophrenia","volume":"57","author":"Heresco-Levy","year":"2005","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.lfs.2016.06.021_bb0040","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S2215-0366(15)00098-X","article-title":"d-serine for the treatment of negative symptoms in individuals at clinical high risk of schizophrenia: a pilot, double-blind, placebo-controlled, randomised parallel group mechanistic proof-of-concept trial","volume":"2","author":"Kantrowitz","year":"2015","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.lfs.2016.06.021_bb0045","doi-asserted-by":"crossref","first-page":"3357","DOI":"10.1021\/jm800200u","article-title":"Synthesis and biological evaluation of d-amino acid oxidase inhibitors","volume":"51","author":"Ferraris","year":"2008","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.lfs.2016.06.021_bb0050","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ab.2011.08.018","article-title":"Development of a high-throughput method for the determination of pharmacological levels of plasma d-serine","volume":"419","author":"Alt","year":"2011","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.lfs.2016.06.021_bb0055","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1177\/0269881109102644","article-title":"The effect of risperidone on d-amino acid oxidase activity as a hypothesis for a novel mechanism of action in the treatment of schizophrenia","volume":"24","author":"Abou El-Magd","year":"2010","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.lfs.2016.06.021_bb0060","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/S0090-9556(25)08211-X","article-title":"Absorption, metabolism and excretion of risperidone in humans","volume":"21","author":"Mannens","year":"1993","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.lfs.2016.06.021_bb0065","doi-asserted-by":"crossref","first-page":"149","DOI":"10.5582\/bst.2014.01034","article-title":"Evaluation of human d-amino acid oxidase inhibition by anti-psychotic drugs in vitro","volume":"8","author":"Shishikura","year":"2014","journal-title":"BioSci. Trends"},{"key":"10.1016\/j.lfs.2016.06.021_bb0070","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.euroneuro.2007.06.006","article-title":"In vitro and in vivo pharmacological profile of AS057278, a selective d-amino acid oxidase inhibitor with potential anti-psychotic properties","volume":"18","author":"Adage","year":"2008","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.lfs.2016.06.021_bb0075","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1023\/A:1007064504007","article-title":"Immunocytochemical localization of d-amino acid oxidase in rat brain","volume":"28","author":"Moreno","year":"1999","journal-title":"J. Neurocytol."},{"key":"10.1016\/j.lfs.2016.06.021_bb0080","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/BF01695140","article-title":"Immunoelection microscopic localization of d-amino acid oxizase in rat-kidney and liver","volume":"19","author":"Perotti","year":"1987","journal-title":"Histochem. J."},{"key":"10.1016\/j.lfs.2016.06.021_bb0085","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/0020-711X(92)90322-R","article-title":"d-amino-acid odixase and its physiological-function","volume":"24","author":"Konno","year":"1992","journal-title":"Int. J. Biochem."},{"key":"10.1016\/j.lfs.2016.06.021_bb0090","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/bmc.365","article-title":"A fully automated amino acid analyzer using NBD-F as a fluorescent derivatization reagent","volume":"18","author":"Aoyama","year":"2004","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.lfs.2016.06.021_bb0095","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1002\/bmc.394","article-title":"Simultaneous determination of d- and l-serine in rat brain microdialysis sample using a column-switching HPLC with fluorimetric detection","volume":"18","author":"Fukushima","year":"2004","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.lfs.2016.06.021_bb0100","doi-asserted-by":"crossref","first-page":"241","DOI":"10.5582\/bst.2012.v6.5.241","article-title":"Fluorimetric assay for d-amino acid oxidase activity in rat brain homogenate by using d-kynurenine as a substrate","volume":"6","author":"Kozaki","year":"2012","journal-title":"BioSci. Trends"},{"key":"10.1016\/j.lfs.2016.06.021_bb0105","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/j.1749-6632.1996.tb33274.x","article-title":"Microbial d-amino acid oxidases (EC 1.4.3.3)","volume":"799","author":"Fischer","year":"1996","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.lfs.2016.06.021_bb0110","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jbiotec.2015.01.026","article-title":"An enzymatic method to estimate the content of l-hydroxyproline","volume":"199","author":"Watanabe","year":"2015","journal-title":"J. Biotechnol."},{"key":"10.1016\/j.lfs.2016.06.021_bb0115","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S1570-0232(02)00715-8","article-title":"Validated method for the determination of risperidone and 9-hydroxyrisperidone in human plasma by liquid chromatography-tandem mass spectrometry","volume":"783","author":"Remmerie","year":"2003","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.lfs.2016.06.021_bb0120","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.jchromb.2007.02.007","article-title":"Determination of risperidone and enantiomers of 9-hydroxyrisperidone in plasma by LC\u2013MS\/MS","volume":"852","author":"Cabovska","year":"2007","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.lfs.2016.06.021_bb0125","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jchromb.2008.04.041","article-title":"Validated LC\u2013MS\/MS methods for the determination of risperidone and the enantiomers of 9-hydroxyrisperidone in human plasma and urine","volume":"870","author":"de Meulder","year":"2008","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.lfs.2016.06.021_bb0130","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1007\/s00213-001-0933-x","article-title":"Brain, plasma and tissue pharmacokinetics of risperidone and 9-hydroxyrisperidone after separate oral administration to rats","volume":"159","author":"Aravagiri","year":"2002","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.lfs.2016.06.021_bb0135","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/BF02245444","article-title":"Regional brain distribution of risperidone and its active metabolite 9-hydroxy-risperidone in the rat","volume":"114","author":"van Beijsterveldt","year":"1994","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.lfs.2016.06.021_bb0140","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1093\/jb\/mvq112","article-title":"Potential cytotoxic effect of hydroxypyruvate produced from d-serine by astroglial d-amino acid oxidase","volume":"148","author":"Chung","year":"2010","journal-title":"J. Biochem."},{"key":"10.1016\/j.lfs.2016.06.021_bb0145","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1192\/S0007125000293653","article-title":"Olanzapine: a basic science update","volume":"37","author":"Bymaster","year":"1999","journal-title":"Br. J. Psychiatry Suppl."},{"key":"10.1016\/j.lfs.2016.06.021_bb0150","series-title":"Interaction of Antipsychotic Drugs with Dopamine Receptor Subtypes","first-page":"43","volume":"Vol. 120","author":"Hartman","year":"1996"},{"key":"10.1016\/j.lfs.2016.06.021_bb0155","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0014-2999(03)01369-4","article-title":"Acute effects of antipsychotic drugs on cardiovascular responses to stress","volume":"464","author":"van den Buuse","year":"2003","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.lfs.2016.06.021_bb0160","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.bbr.2014.09.046","article-title":"Effects of a glycine transporter-1 inhibitor and d-serine on MK-801-induced immobility in the forced swimming test in rats","volume":"278","author":"Kawaura","year":"2015","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.lfs.2016.06.021_bb0165","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1007\/s11064-016-1838-8","article-title":"Modulating NMDA receptor function with d-amino acid oxidase inhibitors: understanding functional activity in PCP-treated mouse model","volume":"41","author":"Sershen","year":"2016","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.lfs.2016.06.021_bb0170","first-page":"269","article-title":"The nature of d-serine-induced nephrotoxicity","volume":"77","author":"Ganote","year":"1974","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.lfs.2016.06.021_bb0175","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.tox.2004.05.001","article-title":"d-serine-induced nephrotoxicity: possible interaction with tyrosine metabolism","volume":"201","author":"Williams","year":"2004","journal-title":"Toxicology"}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320516303770?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320516303770?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T22:49:52Z","timestamp":1748990992000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320516303770"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":35,"alternative-id":["S0024320516303770"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2016.06.021","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of risperidone on plasma d-serine concentration in rats post-administered with d-serine","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2016.06.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}